Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.080
-0.330 (-7.48%)
At close: Dec 10, 2025, 4:00 PM EST
4.188
+0.108 (2.65%)
After-hours: Dec 10, 2025, 7:59 PM EST

Anavex Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2016 - 2020
3657644825378041,359
Upgrade
Market Cap Growth
-52.34%58.72%-10.27%-33.27%-40.83%396.34%
Upgrade
Enterprise Value
2626633433826511,202
Upgrade
Last Close Price
4.088.905.686.5510.3217.95
Upgrade
PB Ratio
3.738.064.013.785.659.01
Upgrade
P/TBV Ratio
3.848.064.013.785.659.01
Upgrade
Quick Ratio
11.5611.568.8012.2714.9214.93
Upgrade
Current Ratio
11.6111.618.8612.3214.9514.97
Upgrade
Return on Equity (ROE)
-43.11%-43.11%-32.81%-33.41%-32.71%-42.58%
Upgrade
Return on Assets (ROA)
-26.51%-26.51%-21.81%-21.59%-18.95%-23.87%
Upgrade
Return on Capital (ROIC)
-29.49%-29.49%-24.12%-23.32%-20.31%-26.29%
Upgrade
Return on Capital Employed (ROCE)
-53.50%-53.50%-42.10%-37.40%-33.40%-24.80%
Upgrade
Earnings Yield
-12.72%-6.07%-8.93%-8.85%-5.96%-2.79%
Upgrade
Buyback Yield / Dilution
-2.18%-2.18%-4.61%-3.74%-10.18%-19.95%
Upgrade
Updated Nov 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q